These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16112634)

  • 1. Interleukin-6: An osteotropic factor influencing bone formation?
    Franchimont N; Wertz S; Malaise M
    Bone; 2005 Nov; 37(5):601-6. PubMed ID: 16112634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors.
    Malaval L; Liu F; Vernallis AB; Aubin JE
    J Cell Physiol; 2005 Aug; 204(2):585-93. PubMed ID: 15751050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-6 receptor expression and IL-6 effects change during osteoblast differentiation.
    Li Y; Bäckesjö CM; Haldosén LA; Lindgren U
    Cytokine; 2008 Aug; 43(2):165-73. PubMed ID: 18555695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for reduced bone formation surface relative to bone resorption surface in female femoral fragility fracture patients.
    Tsangari H; Findlay DM; Zannettino AC; Pan B; Kuliwaba JS; Fazzalari NL
    Bone; 2006 Dec; 39(6):1226-35. PubMed ID: 16926124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoblasts and bone formation.
    Caetano-Lopes J; Canhão H; Fonseca JE
    Acta Reumatol Port; 2007; 32(2):103-10. PubMed ID: 17572649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt signaling: a win for bone.
    Piters E; Boudin E; Van Hul W
    Arch Biochem Biophys; 2008 May; 473(2):112-6. PubMed ID: 18364235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical role for interleukin-6 family-mediated Stat3 activation in osteoblast differentiation and bone formation.
    Itoh S; Udagawa N; Takahashi N; Yoshitake F; Narita H; Ebisu S; Ishihara K
    Bone; 2006 Sep; 39(3):505-12. PubMed ID: 16679075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoinductive effect of bone bank allografts on human osteoblasts in culture.
    de la Piedra C; Vicario C; de Acuña LR; García-Moreno C; Traba ML; Arlandis S; Marco F; López-Durán L
    J Orthop Res; 2008 Feb; 26(2):200-7. PubMed ID: 17853479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 trans-signaling in inflammatory bowel disease.
    Mitsuyama K; Sata M; Rose-John S
    Cytokine Growth Factor Rev; 2006 Dec; 17(6):451-61. PubMed ID: 17045835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The circadian modulation of leptin-controlled bone formation.
    Fu L; Patel MS; Karsenty G
    Prog Brain Res; 2006; 153():177-88. PubMed ID: 16876575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periostin-like-factor in osteogenesis.
    Zhu S; Barbe MF; Liu C; Hadjiargyrou M; Popoff SN; Rani S; Safadi FF; Litvin J
    J Cell Physiol; 2009 Mar; 218(3):584-92. PubMed ID: 19006175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic breast cancer induces an osteoblast inflammatory response.
    Kinder M; Chislock E; Bussard KM; Shuman L; Mastro AM
    Exp Cell Res; 2008 Jan; 314(1):173-83. PubMed ID: 17976581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progeroid syndrome as a model for impaired bone formation in senile osteoporosis.
    Hishiya A; Watanabe K
    J Bone Miner Metab; 2004; 22(5):399-403. PubMed ID: 15316860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo.
    Axmann R; Böhm C; Krönke G; Zwerina J; Smolen J; Schett G
    Arthritis Rheum; 2009 Sep; 60(9):2747-56. PubMed ID: 19714627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and role of interleukin-6 in distraction osteogenesis.
    Cho TJ; Kim JA; Chung CY; Yoo WJ; Gerstenfeld LC; Einhorn TA; Choi IH
    Calcif Tissue Int; 2007 Mar; 80(3):192-200. PubMed ID: 17340223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.
    Nakamura A; Ly C; Cipetić M; Sims NA; Vieusseux J; Kartsogiannis V; Bouralexis S; Saleh H; Zhou H; Price JT; Martin TJ; Ng KW; Gillespie MT; Quinn JM
    Bone; 2007 Feb; 40(2):305-15. PubMed ID: 17049328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription factors controlling osteoblastogenesis.
    Marie PJ
    Arch Biochem Biophys; 2008 May; 473(2):98-105. PubMed ID: 18331818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [P2 purinergic receptors: regulation of bone metabolism and therapeutic potential?].
    Solgaard M; Jørgensen NR
    Ugeskr Laeger; 2005 Aug; 167(34):3152-6. PubMed ID: 16117911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoblastic cells: differentiation and trans-differentiation.
    Kassem M; Abdallah BM; Saeed H
    Arch Biochem Biophys; 2008 May; 473(2):183-7. PubMed ID: 18406334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoclast-osteoblast communication.
    Matsuo K; Irie N
    Arch Biochem Biophys; 2008 May; 473(2):201-9. PubMed ID: 18406338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.